Work

mTOR complex 2 is an integrator of cancer metabolism and epigenetics

Year: 2020

Type: article

Source: Cancer Letters

DOI: 10.1016/j.canlet.2020.03.001

Authors: Kenta Masui, Mio Harachi, Webster K. Cavenee, Paul S. Mischel, Noriyuki Shibata

Institutions: Tokyo Women's Medical University, University of California San Diego, Ludwig Cancer Research

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Takeda Science Foundation, National Institutes of Health, Japan Society for the Promotion of Science, National Institute of Neurological Disorders and Stroke

Awards: mTOR-dependent hypomethylator phenotype in glioblastoma, The role of mTORC2 in reprogramming cancer cell metabolism

OpenAlex ID: W3010638295

FWCI: 2.004

Cites: 110

Cited by: 38

Related to: 10